Quantcast
Last updated on April 19, 2014 at 21:20 EDT

Latest Carpuject Stories

2009-02-25 10:01:00

- Safety Protocol Integration Enhances Market-Leading GemStar Medication Management Pump - LAKE FOREST, Ill., Feb. 25 /PRNewswire-FirstCall/ --Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced the introduction of the GemStar(R) SP infusion system with GemStar(TM) Infusion Suite software, an advanced version of the market-leading, multi-application, GemStar pump. The GemStar SP infusion system is designed to help caregivers...

2009-01-26 10:00:00

LAKE FOREST, Ill., Jan. 26 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today announced that it will host a conference call to discuss its fourth-quarter and full-year 2008 results and projections for 2009 on Tuesday, Feb. 17, 2009, at 8 a.m. Central time. The company will release its fourth-quarter and full-year 2008 results earlier that morning, before the U.S. stock market open and the conference...

2008-10-22 15:00:30

MENLO PARK, Calif., Oct. 22 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing systems for Enabling Regenerative Medicine(TM), announced today that it has signed an agreement with Hospira, Inc. to develop and commercialize StemCor's proprietary System for the harvest of bone marrow. (Logo: http://www.newscom.com/cgi-bin/prnh/20071030/STEMCORSYSTEMSLOGO) StemCor will develop the System for Hospira, and Hospira will manage the clinical trial program, leading to...

2008-08-21 15:01:07

LAKE FOREST, Ill., Aug. 21 /PRNewswire-FirstCall/ -- Hospira, Inc. , a global specialty pharmaceutical and medication delivery company, today announced new national agreements with Premier Purchasing Partners. The multi-year contracts will provide Premier's 2,000 member hospitals with access to special pricing and terms pre-negotiated by Premier for Hospira's general-purpose medication infusion devices, related sets and disposables, along with intravenous (I.V.) solutions, nutritionals,...

2008-07-02 09:01:03

Altea Therapeutics announced today that it has entered into a partnership with Hospira, Inc., a global specialty pharmaceutical and medication delivery company, for the development and commercialization of an undisclosed product utilizing the Company's proprietary PassPort(TM) Transdermal Delivery System. Under the terms of the agreement, Altea Therapeutics has granted Hospira exclusive worldwide rights to develop and commercialize the product. Altea Therapeutics will fund certain Phase...